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a  b  s  t  r  a  c  t
NAD  is  not  only  an  important  cofactor  in redox  reactions  but has also  received  attention  in recent  years
because  of its  physiological  importance  in  metabolic  regulation,  DNA repair  and signaling.  In contrast  to
the redox  reactions,  these  regulatory  processes  involve  degradation  of  NAD  and  therefore  necessitate  a
constant replenishment  of its cellular  pool.  NAD  biosynthetic  enzymes  are  common  to almost  all  species
in all  clades,  but  the  number  of NAD degrading  enzymes  varies  substantially  across  taxa.  In particular,
vertebrates,  including  humans,  have  a  manifold  of NAD degrading  enzymes  which  require  a high  turnover
of  NAD.  As there  is currently  a lack  of  a systematic  study  of how  natural  selection  has  shaped  enzymes
involved  in  NAD metabolism  we  conducted  a comprehensive  evolutionary  analysis  based on intraspeciﬁc
variation  and  interspeciﬁc  divergence.  We  compare  NAD biosynthetic  and  degrading  enzymes  in  four
eukaryotic  model  species  and  subsequently  focus  on human  NAD  metabolic  enzymes  and  their  orthologs
in other  vertebrates.  We  ﬁnd  that  the  majority  of  enzymes  involved  in  NAD  metabolism  are  subject  to
varying  levels  of  purifying  selection.  While  NAD  biosynthetic  enzymes  appear  to  experience  a rather
high  level  of  evolutionary  constraint,  there  is evidence  for positive  selection  among  enzymes  mediating
NAD-dependent  signaling.  This  is  particularly  evident  for members  of  the  PARP family,  a diverse  protein
family  involved  in  DNA  damage  repair  and  programmed  cell  death.  Based  on  haplotype  information  and
substitution  rate  analysis  we  pinpoint  sites  that  are potential  targets  of  positive  selection.  We  also  link
our  ﬁndings  to a three  dimensional  structure,  which  suggests  that  positive  selection  occurs  in domains
responsible  for  DNA  binding  and polymerization  rather  than  the NAD  catalytic  domain.  Taken  together,
our  results  indicate  that  vertebrate  NAD  metabolism  is still  undergoing  functional  diversiﬁcation.
Crown  Copyright  © 2014  Published  by Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY
license  (http://creativecommons.org/licenses/by/3.0/).
1. Introduction
Understanding how selection and genetic drift have shaped the
composition of proteins is a central problem in population genet-
ics and molecular evolution. Considering the complex interplay of
enzymatic proteins and the critical homeostatic equilibrium they
have to maintain it is not surprising that most amino acid chang-
ing mutations affecting enzymes will be deleterious [1,2]. Due to
recent advances in DNA sequencing technology it is now possible
to obtain whole genome information from numerous non-model
organisms and mutational variation of multiple individuals of the
same species at reasonable costs [3,4]. Patterns of sequence diver-
gence between species and variation in natural populations can
be used to reveal underlying selective ﬁtness effects of mutations
∗ Corresponding author. +44 (0) 1142220062.
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and can help to understand how natural selection has shaped the
functions of enzymes and other proteins [2,5,6].
Enzymes are often involved in a complex network of interac-
tions [7]. Various theories exist which aim to explain how complex
enzyme networks can evolve [8]. A currently favored model, the
patchwork model [9,10], proposes that pathways evolve from a
system of enzymes with a broad substrate speciﬁcity to enzymes
with specialized functions through gene duplications. The rate at
which a particular enzyme is evolving within a network depends
on a number of factors, including how its products are involved
in interactions with other gene products and where these prod-
ucts are located within the network [11,12]. It has been proposed
that the position of an enzymes within a metabolic pathway (e.g.
upstream or at a branch point) may  play a role, even though the
models are restricted to relatively simple pathways [13,14]. In
brief, evolutionary theory suggests that important enzymes tend
to accumulate fewer deleterious substitutions and undergo positive
selection more frequently [13].
http://dx.doi.org/10.1016/j.dnarep.2014.07.005
1568-7864/Crown Copyright © 2014 Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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Fig. 1. Schematic representation of the NAD pathway model. Enzymes are subdivided into biosynthetic (green) and degrading enzymes (red). NAD key metabolites are
circled,  remaining substrates and products are indicated by reaction arrows. For further details and abbreviations see [16]. (For interpretation of the references to color in
this  ﬁgure legend, the reader is referred to the web version of this article.)
NAD (nicotinamide adenine dinucleotide) is a key metabolite
[15] as it participates in a vast number of redox reactions, but
is also involved in a variety of signaling reactions. In contrast
to redox reactions, these signaling reactions include degradation
of NAD and require a permanent replenishment of cellular NAD
pools. In yeast and human, NAD can be synthesized via a num-
ber of possible routes [15] which illustrates the fact that NAD
metabolism can be considered as a relatively complex metabolic
network (Fig. 1). From a phylogenetic perspective the occur-
rence of NAD biosynthetic enzymes is remarkably conserved
across taxa [16], with only a few exceptions [17,18]. However
the diversiﬁcation of vertebrates species is associated with an
diversiﬁcation of NAD degrading enzymes [16]. In particular,
mammals, including humans, have numerous NAD degrading
enzymes. Because of the physiological importance of NAD sig-
naling, the effect of the constant turnover of NAD on NAD
biosynthesis has gained increased attention over the past years
[19–21].
ADP-ribosyltransferases constitute the largest group of NAD
degrading enzymes. They transfer the ADP-ribose moiety of NAD
onto acceptor proteins coincident with the release of nicotinamide
[22]. ADP-ribosyltranferases can be distinguished as either mono-
ADP-ribosyltransferases (mARTs) or poly-ADP-ribosyltransferases
(PARPs), even though this classiﬁcation is inaccurate [22], since it is
unclear if all PARPs truly involve a poly-ADP-ribose catalytic func-
tion. However, different PARPs have been experimentally proven
to be involved in enzymatic processes such as DNA repair, main-
tenance of genomic stability and response to oxidative stress [23].
The PARP family consists of 17 family members, but the majority
of poly-ADP-ribose is synthesized by PARP1 [24] and some PARP
family members remain poorly characterized experimentally [22].
Even though the metabolic and biochemical properties of
human NAD metabolic enzymes have been intensely studied, there
is currently a lack of a systematic evolutionary analysis of how
natural selection has shaped sequence patterns of NAD metabolic
enzymes. Because of the complexity of the NAD metabolic network
(Fig. 1) it is difﬁcult to make clear predictions on how evolutionary
forces have shaped the sequence composition of NAD metabolic
enzymes. Given the universality of NAD, its biosynthesis and the
physiological importance of NAD degrading enzymes it seems plau-
sible that mutations affecting NAD metabolic enzymes are likely
to introduce harmful changes leading to enzymatic malfunction.
However based on the distribution of NAD metabolic enzymes
across taxa [16] it becomes apparent that vertebrates harbour
NAD degrading enzymes that are absent in other species. These
“new” enzymes are likely to be the result of duplication events
and therefore may  gain new or modiﬁed functions according to
the patchwork model [25,26]. From an evolutionary perspective,
phylogenetically young genes tend to evolve under relaxed selec-
tive constraint and possibly undergo adaptation more frequently
[27]. We  therefore postulate that among the genes encoding NAD
degrading enzymes there are candidates that should show signa-
tures of positive selection or the random accumulation of mutations
as a part of subfunctionalization and therefore show a higher rate
of protein evolution.
In this study we  test the hypothesis that NAD biosynthetic
and degrading enzymes show differences in their evolutionary
patterns. We  start our analysis on four model species, humans,
mice, Drosophila and Arabidopsis and present evidence for differ-
ences in divergence and diversity between the two enzyme groups.
We show that the direction of selective constraint is inconsistent
between the species, which may  reﬂect differences in their effec-
tive population sizes. Based on 50 human NAD metabolic enzymes,
we subsequently calculate evolutionary rates and determine the
role of positive selection for vertebrate enzymes involved in NAD
metabolism. We  particularly focus on two members of the PARP
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family, PARP4 and PARP14. Human PARP4 is an enzyme with an
unusually large number of high frequency segregating variation
and shows a strong signature of population differentiation, as well
as a possible signature of population speciﬁc positive selection.
We reveal that the signature of population differentiation and
positive selection coincides with the end of a homologous region
which undergoes unequal recombination with an adjacent pseu-
dogene. Secondly we provide strong evidence that PARP14 has
been undergoing recurrent events of positive selection within the
vertebrate clade. We  identify potentially positively selected sites
that lie in the functional domains of the PARP14 protein, but out-
side its catalytical domain, and are likely to have an impact on
regulation and target substrate binding. We  conclude that among
NAD degrading enzymes there are fast evolving enzymes, illus-
trating an ongoing functional diversiﬁcation in mammalian NAD
metabolism.
2. Materials and methods
2.1. NAD pathway model
We  focused on 50 human NAD metabolic enzymes based on a
previous study and the availability of sequence data [16], a detailed
list of gene identiﬁers can be found in Supporting dataset S1. We
did not include human PARG in the study as we could not identify
the gene in the HapMap dataset. We  classify enzymes as either NAD
biosynthetic or NAD degrading (Fig. 1) depending on whether they
are part of a biosynthetic pathway or not [15].
2.2. Model species comparisons
We  obtained sequence divergence and diversity of four model
species: humans, Arabidopsis thaliana, Drosophila melanogaster and
mice [16]. Sequence information was retrieved as follows: For
humans we obtained information of the human genome project
[28], coding SNPs for each gene were extracted from > 1000 human
individuals and were resampled to 20 individuals using binomial
sampling which is a reasonable approximation due to the large
sample size. We  also use this information to identify SNPs that
segregate at high frequency (> 20%) within the human popula-
tion. Divergence was obtained using the genome of macaque [29]
to avoid misinference by segregating polymorphisms [30]. For
Drosophila we  used sequencing information from 17 sub-Saharan
individuals [31] and outgroup information to D. yakuba [32], for
Arabidopsis we used sequence information from 80 Arabidopsis
thaliana accessions [33] and outgroup information to A. lyrata [34]
and sequence information from ten wild house mice (Mus  muscu-
lus castaneus)  individuals [35] using rat as outgroup [36]. We  focus
on protein coding parts and obtain the number of nonsynonymous
polymorphisms (Pn) and synonymous polymorphims (Ps) as well as
the number of nonsynoymous substitutions (Dn) and synonymous
substitution (Ds) for each gene. Because some genes are absent in a
species or have little or no polymorphism or substitutions we sum
data across genes for the two enzyme groups, NAD biosynthetic
or NAD degrading. Estimates for Dn and Ds were calculated using
codeml package of PAML (runmode = −2) or in case of mouse-rat
comparison provided from the authors [35] as the number of four-
fold and zerofold divergent sites. Signiﬁcance for the contrast of
Pn/Ps and Dn/Ds between enzyme groups was addressed by per-
mutation tests. A classic McDonald Kreitman (MK) test [5] was
conducted by contrasting patterns of polymorphisms and diver-
gence. Within the MK  framework an excess of nonsynonymous
divergence to nonsynonymous polymorphisms suggests the action
of adaptive evolution.
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Fig. 2. Evolutionary rates for 50 NAD metabolic enzymes measured as dn/ds based
on  human NAD enzymes and their orthologs in other vertebrate species. Genes that
show signiﬁcant evidence for positive selection based on site test (see Section 2) are
boxed in red. Parameter estimates for the site test results are shown in Table 2. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred
to  the web  version of this article.)
2.3. Rates of molecular evolution of vertebrate NAD metabolic
enzymes
We identiﬁed orthologous sequences for the 50 human enzymes
using whole genome information from 22 vertebrate species which
we obtained from Ensembl [37] (full species list in Supporting
dataset S1). To identify homologs we  used the best BLAST hit [38]
followed by a ﬁltering procedure. We  excluded sequences which
were too long or too short (>20% in comparison to the human
sequence) and for which too many positions did not have sequence
information (>5 nt missing). Therefore the number of outgroup
sequences varies for the 50 enzymes, either because a particular
gene is absent or poorly sequenced. The remaining sequences were
aligned with MAFFT [39] and unreliable alignment positions were
removed with GUIDANCE [40]. The ﬁnal alignment was processed
with PAL2NAL [41] and used as input for PAML [42]. Synonymous
mutations can be regarded as neutral or nearly neutral [43], and
this characteristic may  be used to infer selective effects of amino
acid altering mutations [5,44–47]. The rate of molecular protein
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evolution can be measured by the ratio ω = dn/ds, where dn and ds
are, respectively, the numbers of nonsynonymous and synonymous
differences per nonsynonymous and synonymous site between two
sequences [48–50]. PAML uses a maximum likelihood approach to
obtain ω estimates for the provided phylogeny using certain model
assumptions. To obtain ω for each set of orthologous enzymes
we assumed a constant ω for the whole phylogeny (model M0,
one-ratio model). We  also conducted site tests which assumes
heterogeneity in ω within genes. For this a likelihood ratio test
(LRT) is conducted to address a signiﬁcant ﬁt of a more complex
model in comparison to a nested simpler model. Evidence of posi-
tive selection is based on the comparison of the site model models
M1a  and M2a  [51,47] by applying an LRT with degrees of free-
dom (d.f.) = 2 and P< 0.001 which corresponds to a P-value of
P = 0.05 with Bonferroni correction for multiple testing. Models
M1a  and M2a  assume two classes of sites, either purifying selec-
tion (ω< 1) or neutrality (ω = 1), but M2a  additionally allows for
sites with ω> 1. To identify speciﬁc sites with ω> 1 we used the
Naive Emprical Bayes (NEB) procedure as implemented in PAML
and selected sites with a posterior probability > 0.5 to have ω>
1.
2.4. PARP4: Fst and H-statistic
To investigate patterns of polymorphism of the human PARP4
gene we included noncoding regions (e.g. UTR and introns).
We calculated Fst [52], a measurement of population differ-
entiation, using the R-package Popgenome [53]. Additionally,
we calculated Fay and Wu’s H statistic [54] for each of the
human population separately using the software package DHtest
(http://zeng-lab.group.shef.ac.uk). Fay and Wu’s H measures an
excess of high frequency derived variants in comparison to inter-
mediate alleles, which should be present if recombination occurs
during a selective sweep [55]. We  obtained genomic information
covering all exons and introns of human PARP4 on chromosome 13
spanning a region of 85 kb for 1092 individuals from 14 human
population using the Hapmap data [28]. Test statistics (Fst and
Wu’s H) were calculated for overlapping sliding windows (3 Kb
window size and step size 0.5 Kb). Conﬁdence intervals for Fst val-
ues were obtained by calculating minimum and maximum Fst of
100 random subsamples of 546 individuals. PARP4 is also under-
going gene conversion from a nearby pseudogene (Dumont et al,
personal communication), e.g. as a result of ectopic recombina-
tion [56]. The PARP4 pseudogene is located around 5 Mb before
the PARP4 gene on chromosome 13 covering a region of 32 Kb and
shares 28 SNPs with PARP4, of which two are coding (Supporting
dataset S1)
3. Results
Here we conducted a comprehensive evolutionary analysis
of NAD metabolic enzymes by using intraspeciﬁc variation and
sequence divergence to other species. We restricted our analyses
to the most common type of mutations, point mutations. In partic-
ular, we tested the hypothesis that NAD degrading enzymes show
faster rates of protein evolution in comparison to NAD biosynthetic
enzymes. First, we compared the evolutionary patterns of NAD
biosynthetic and degrading enzymes in four model species. We
used a general metabolic model derived from humans and yeast
[15] and classiﬁed enzymes as either being NAD biosynthetic or
NAD degrading (Fig. 1). We  subsequently focused on human NAD
metabolism, based on sequence variation and divergence of 50
human NAD metabolic enzymes to elucidate candidate enzymes
with sequence patterns that are consistent with an evolutionary
functional transition.
3.1. Evolutionary patterns of NAD metabolic enzymes vary across
model species
As an initial analysis we compared intra- and interspeciﬁc
protein coding sequence variation of NAD metabolic enzymes
in four model species (human, mouse, Drosophila and Arabidop-
sis) for which data is publicly available. A measurement of the
currently acting selective forces can be obtained by contrasting
the ratio of nonsynonymous polymorphism to synonymous poly-
morphisms (Pn/Ps). Assuming that nonsynonymous mutations are
largely deleterious or neutral, a relaxed action of purifying selec-
tion or an increased number of effectively neutral mutations would
lead to higher Pn/Ps values. Indeed, we  found that in Drosophila
melanogaster Pn/Ps is signiﬁcantly higher for enzymes which con-
sume NAD than for biosynthetic enzymes (Table 1). The same trend
is observed in the other three species, however not signiﬁcant. One
possible reason may  be a lack of statistical power because the num-
ber of polymorphisms is relatively low and the number of protein
sequences is limited by the design of the study.
The ratio of nonsynonymous substitutions to synonymous
substitutions (Dn/Ds) is a measurement of the evolutionary rate of
protein evolution. Relaxed purifying selection or frequent positive
selection lead to an elevation of Dn/Ds, because nonsynonymous
mutations tend to become ﬁxed, i.e., replace the initial allele in
the whole population, more frequently. Therefore it is important
to disentangle the predominant type of selection, which however
is not trivial [57]. Regarding NAD metabolic enzymes, we found
that Dn/Ds is signiﬁcantly different in three species – humans, mice
and Arabidopsis (Table 1). In humans and Arabidopsis there is an
increased rate of Dn/Ds for NAD degrading enzymes in compari-
son to NAD biosynthetic enzymes, but for mice the trend is the
opposite. A possible explanation for this pattern are differences in
the effective population size (Ne, reviewed in [58]) between these
species, because higher levels of Ne facilitate the action of selection.
Humans and Arabidopsis have relatively small effective population
sizes [30] and show little evidence for adaptive evolution [6,59]. In
contrast, Ne of wild mice is relatively large and as a consequence
selection is more efﬁcient [60]. Indeed, mice undergo frequent
adaptive evolution [60,35] which leads to increased levels of Dn/Ds.
To test if positive selection has contributed to the divergence of NAD
metabolic enzymes we  contrasted patterns of polymorphisms and
divergence (MK-test, [5]). We  found evidence for positive selection
in mice and Drosophila (Table 1), both species with large Ne and in
the case of Drosophila this is only signiﬁcant for NAD biosynthetic
enzymes, but not NAD degrading enzymes. Theses results suggest
that differences in Dn/Ds in mice are largely caused by increased
rates of adaptation, rather than relaxed levels of purifying selection.
In contrast, for humans and Arabidopsis the differences between
NAD degrading and NAD biosynthetic enzymes are likely caused by
differences in the intensity of purifying selection. As a consequence,
the role of positive selection in human NAD degrading enzymes
appears limited, however it may  be obscured by the dominating
action of purifying selection.
3.2. Analysis of substitution rate variation mammalian species
To measure the rate of evolution we use nonsynonymous to
synonymous substitution rates (ω) which provides a sensitive mea-
sure of selective pressure at the protein level. ω values <1, = 1,
and >1 indicate purifying selection, neutral evolution, and positive
selection, respectively. We  obtained orthologous sequences from
vertebrate species for 50 human NAD metabolic enzymes (see Sec-
tion 2) and calculated evolutionary rates assuming a constant ω
between species (one-ratio model). ω ratios vary greatly between
enzymes (Fig. 2) from dn/ds = 0.008 for Tankyrase to dn/ds = 1.08
for CD38. The top 14 enzymes with the highest ω ratios are NAD
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Fig. 3. Alignment of PARP14 homologs covering macro domain 1 and macro domain 2 (human residues 800–1200). Red boxes indicate sites that have been identiﬁed to
be  evolving under positive selection. Green blocks indicate sites for substrate binding and cyan blocks indicate macro domain 1 and 2 interacting sites [62]. Site 903 has
nonpolar interactions with sites 1105 and 1143. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
degrading enzymes. Regarding the NAD biosynthetic enzymes PNP
and NMNAT3 show the highest evolutionary rates, NADK and
NMNAT2 show the lowest rates. Since variation in ω ratio can be
the result of differences in the type of selection, we investigated
the role of positive selection. To identify whether increased rates of
evolution are caused by events of positive selection, we conducted
site-speciﬁc tests with PAML and found evidence for positive selec-
tion in four enzymes of which all belong to the NAD degrading
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Table 1
Diversity (Pn/Ps) and divergence (Dn/Ds) information for NAD biosynthetic and NAD
degrading genes in four species. A test of positive selection (McDonald Kreitman
(MK) test) was  conducted, which contrasts the level of Pn/Ps and Dn/Ds .
Species NAD
biosynthesis
NAD
degradation
Homo sapiens
Pn/Ps 0.28 ≈ 0.45
Dn/Ds 0.26 < 0.39
MK-test n.s. n.s.
Mus  musculus
Pn/Ps 0.10 ≈ 0.12
Dn/Ds 0.32 > 0.26
MK-test ** **
Drosophila melanogaster
Pn/Ps 0.03 < 0.06
Dn/Ds 0.06 ≈ 0.06
MK-test * n.s.
Arabidopsis thaliana
Pn/Ps 0.21 ≈ 0.24
Dn/Ds 0.12 < 0.16
MK-test n.s. n.s.
n.s. – not signiﬁcant; <, > signs indicate signiﬁcant differences between the two
enzyme groups using a permutation test; ≈ indicates no signiﬁcant difference.
* P < 0.05.
** P < 0.001.
enzymes (Fig. 2 and Table 2). Interestingly, all four enzymes are
members of the PARP family (see 1), and in particular, PARP9,
PARP14 and PARP15 form the group of macro domain containing
PARPs. The macrodomain was initially described in histones and is
involved in epigenetic regulation as a metabolite sensor on chro-
matin [61]. Recently a three dimensional structure of PARP14 has
been published with focus on its macrodomains including binding
sites and interactions between macro domains 1 and 2 [62]. We
pinpoint 27 sites that show a signature of positive selection and
lie in the macro domains 1 and 2 (Fig. 3), which is a signiﬁcant
enrichment compared to the rest of the protein (Fisher exact test,
P = 0.016).
3.3. Amino acid altering variation segregating in human
populations
We  retrieved natural variation of human individuals from the
Hapmap Genome project [28] to identify amino acid altering single
nucleotide polymorphisms (SNPs) in NAD metabolic enzymes
that are currently segregating in the human population at high
frequencies (> 20%, Table 3). High frequency SNPs are likely to
be polymorphisms which are either selectively neutral, under
balancing selection or currently undergoing positive selection,
but unlikely to have strong deleterious effects. Altogether we
determined 21 high frequency amino-acid changing variants
of which 4 belong to NAD biosynthetic enzymes (Table 3). The
remaining 17 changes occur in ARTs and PARPs. Among the 21
Table 2
Human NAD metabolic enzymes with evidence for positive selection based on sub-
stitution rate analysis using vertebrate orthologs. Likelihood ratio test P-values
are derived from the comparison of model M1a  (nearly neutral model) and M2a
(neutral+positive selection) to test for positive selection assuming hetereogeous ω
among sites. p denotes the proportion of sites with w > 1, the number of orthologous
sequences is denoted by # Seqs.
Enzyme LRT P-valuea # Seqs Parameter estimates
PARP9 0.0 7 p = 0.13, ω = 4.33
PARP13 3.13 × 10−13 3 p = 0.05, ω = 15.05
PARP14 0.0 11 p = 0.06, ω = 3.41
PARP15 3.46 × 10−7 5 p = 0.07, ω = 4.65
a Site models M1a vs M2a.
Table 3
Amino acid changing mutations of human NAD metabolic enzymes currently segre-
gating at high frequency (> 20%) in the human population. Evolutionary rare changes
based on negative PAM250 scores are in bold.
Enzyme Amino acid change (position) Frequency
NRK V ↔ M (358) 0.31
NADK N ↔ K (262) 0.28
NT5E T ↔ A (376) 0.76
PNP G ↔ S (51) 0.22
ART1 L ↔ P (257) 0.55
ART3 S ↔ L (341) 0.47
ART4 D ↔ N (265) 0.28
PARP13 H ↔ Q (565) 0.26
R  ↔ K (485) 0.25
PARP15 G ↔ R (628) 0.23
PARP4 A ↔ P (1656) 0.42
P  ↔ T (1328) 0.38
G ↔ R (1280) 0.38
G  ↔ A (1265) 0.38
V  ↔ A (1065) 0.64
A  ↔ T (899) 0.66
S ↔ N (873) 0.23
PARP9 Y ↔ C (528) 0.54
PARP10 V ↔ A (630) 0.54
L  ↔ P (395) 0.35
I  ↔ V (249) 0.38
high frequency mutations are 5 that are evolutionarily uncommon
based on the PAM250 substitution score matrix [63] and they all
occur in NAD degrading enzymes. Most strikingly we  ﬁnd that
PARP4 (also dubbed vault-PARP [64]) has numerous high frequency
nonsynonymous polymorphisms. A possible cause for this pattern
is that PARP4 is currently undergoing a selective sweep [55]
resulting in co-segregating SNPs. Another explanation could result
from the fact that PARP4 has experienced gene conversion from a
pseudogeneized paralog (Dumont et al., personal communication).
Pseudogenes are genes that lost their protein coding ability and are
therefore dysfunctional [65]. However, there are numerous poly-
morphisms at homologous positions that are segregating in both
PARP4 and the PARP4 pseudogene likely caused by recombination
events of the two different loci (ectopic recombination [56]).
However, the region of non-homologous recombination does not
entirely cover the PARP4 gene, but a stretch of around 38 Kb that
includes the last 10 of the 33 PARP4 exons (e.g., the region encoding
the C-terminus of the PARP4 protein, Fig. 4). To investigate these
hypotheses in greater detail we  retrieved haplotype information
for the entire PARP4 gene along with the genomic alignment to
chimpanzee. Based on a sliding window approach (see Section 2)
we elucidated two  remarkable patterns (Fig. 4). First there is a
peak in the population structure, as measured by Fst, which is
near the end of the nonhomologous recombining region. Second,
we observe a signature of positive selection based on Fay and
Wu’s H statistic, which however appears to differ among the 14
populations. These population speciﬁc extreme values of H are also
observed near the end of recombination region. Interestingly, we
do not ﬁnd an excess of diversity or divergence in the recombining
region in comparison to the rest of the enzyme (results not shown).
4. Discussion
Taking into consideration the centrality and universality of NAD
and the fact that there is no known mechanism of extracellular
uptake of NAD, it is clear that there is the need for cellular NAD
synthesis during cell growth and a constant recycling of NAD to
satisfy the needs of NAD dependent reactions. The importance of
NAD metabolism is also reﬂected in evolutionary terms, because
of the widespread abundance of NAD biosynthetic enzymes in
almost all genomes that have been sequenced so far [66,16].
However, within one organism multiple enzyme pathways may
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biosynthesize NAD, and the relative contribution of the different
pathways to the overall cellular NAD content is still unknown
[15]. Attempts to model pathways taking compartmentalization or
even interactions between different tissues into account have been
restricted to simple model systems as a consequence of lack of data
due to experimental limitations [67–69]. Flux control analysis can
predict the importance of an enzyme within a metabolic network
[70]. However, at the current state there is clearly the need for a
detailed analysis to link the outcome of ﬂux distributions with an
evolutionary interpretation [71].
A major predictor of an enzyme’s evolutionary rate is its
functional importance, but there are other factors which can inﬂu-
ence patterns of sequence evolution of proteins, both within and
between species [72]. This includes the local recombination rate,
the linkage to nearby variation, epistatic effects and the effec-
tive population size (Ne) [73,30]. It is therefore difﬁcult to derive
clear predictions about how NAD metabolic enzymes are currently
evolving and which evolutionary factors may  have driven sequence
divergence of NAD metabolic enzymes between vertebrate species.
As a general assumption, we hypothesized that NAD biosynthetic
enzymes should show a pattern of stronger selective constraint in
contrast to NAD degrading enzymes which should reveal signa-
tures of relaxed purifying selection and potentially show signs of
functional diversiﬁcation. In agreement with our prediction Pn/Ps,
the number of nonsynonymous polymorphisms over synonymous
polymorphisms, is consistently higher for NAD degrading enzymes
in four model species. This illustrates that selection against dele-
terious mutations is less efﬁcient or that more mutations tend to
be effectively neutrally evolving in NAD degrading enzymes. The
latter scenario is possible as a consequence of duplication events,
under a model of subfunctionalization. Under such a scenario dupli-
cated enzymes gain a specialized function and will therefore tend
to evolve neutrally in the parts of the protein that do not exhibit a
function anymore [26,74]. NAD degrading enzymes, such as PARPs,
SIRTUINs and ARTs form protein families that are likely to have
originated from duplication events. We  also observe signiﬁcant
differences in the evolutionary rates between the two  enzyme
classes in three of the four model species. However, they are incon-
sistent among species which is possibly a consequence of the
differences in their Ne. We  showed that biosynthetic enzymes in
humans and Arabidopsis exhibit reduced evolutionary rates, but
appear to be evolving faster in mice, which may  be attributed to
the action of positive selection for which we ﬁnd evidence in mice
and Drosophila.
Based on substitution rate analysis of human metabolic enzymes
along with their orthologs in other vertebrate species, we observe
that the highest rates of protein evolution occur in NAD degrading
enzymes, but it also becomes apparent that enzymes involved in
biosynthesis are not consistently slowly evolving enzymes (Fig. 2).
Even more surprisingly, there appears to be a substantial variation
of evolutionary rate within both enzyme groups, NAD degrading
and NAD biosynthesizing enzymes. One of the reasons for this
heterogeneity may  be caused by differences in the Ne of the dif-
ferent vertebrate species, as the number of species included differs
for each of the enzymes due to technical (e.g. missing sequence
information) or biological reasons (e.g. absence of an enzyme). Nev-
ertheless, a cause for the observed heterogeneity in dn/ds is the
action of positive selection. We  ﬁnd evidence for four enzymes
where positive selection has driven sequence divergence within
the vertebrate lineage. Another aspect which explains the substan-
tial variation is the unlikely assumption of a constant evolutionary
rate within the whole phylogeny, as the rate variation may  be inﬂu-
enced by few species. A large scale study of >16,000 human genes
found around 2.4% of genes to be evolving under positive selection
[75] in six mammalian genomes (human, chimp, macaque, mouse,
rat and dog), which is signiﬁcantly lower than 8% (binomial test,
P = 0.03) identiﬁed in this study. This suggests two  aspects, (1) NAD
metabolism is enriched in genes undergoing positive selection and
(2) positive selection may  be in particular, acting in species that
have not been included in the study of Kosiol et al. [75]. We  ﬁnd
no evidence for positive selection based on branch speciﬁc test, as
conducted previously [75], within the human lineage (results not
shown).
Speciﬁc enzyme characteristics may  cause evolutionary rate
variation within proteins. There is striking evidence for evolu-
tionary rate variation within vertebrate NMNATs [76], arguably
the most central enzyme of NAD biosynthesis. The rate varia-
tion is caused by ISTIDs (isoform-speciﬁc targeting and interaction
domains), which are interior stretches of the protein with an
unknown three dimensional conformation. This potential confor-
mational relaxation leads to elevated rates of protein evolution
[76]. Indeed, NMNAT1 and NMNAT3 are among the fastest evolving
NAD biosynthetic enzymes (Fig. 2), even though for two  of the three
ISTIDs a functional role has been experimentally veriﬁed [76]. How-
ever, protein families such as NMNATs and PARPs are not generally
fast-evolving, e.g. NMNAT2 and PARP family members (Tankyrases
and PARP6) are among the slowest evolving proteins. Among the
slowest evolving enzymes is also NAMPT, the rate-limiting enzyme
of NAD biosynthesis [77,78], which was  believed to be only present
in vertebrates until very recently. However there is accumulating
evidence, that this enzyme is present in lower eukaryotes and has
been lost several independent times in various non-vertebrate lin-
eages [16,18]. However, enzymatic functionality of non-vertebrate
NAMPT has yet to be shown.
Three macro-domain containing PARPs are among the enzymes
with the highest evolutionary rates, and show a signature of pos-
itive selection. To identify potential functional roles of sites under
positive selection we used a recently published three dimensional
structure of PARP14 which includes binding sites as well as inter-
action sites of domains within the protein [62]. There are several
sites subject to positive selection adjacent to binding sites, but more
importantly, ﬁve macro domain interacting sites appear to have
undergone positive selection (Fig. 3). Interestingly, three of the
ﬁve sites form two  nonpolar interactions between macro domain
1 and macro domain 2 [62], suggesting a potential coevolutio-
nary mechanism. This suggest that not the NAD binding sites but
the binding sites for the substrate on which the NAD moiety is
transferred appears to be under evolutionary diversiﬁcation. Taken
together, the substitution rate analysis and the striking example of
PARP14 shows a potential role of positive selection and illustrates
that NAD degrading enzymes are under functional diversiﬁcation.
This also implies that experimentally proven functionality, e.g.
in mouse, may  not apply to other species, such as humans, and
that a functional transfer from model species may  be mislead-
ing.
Sequence variation in human NAD metabolic enzymes reveals
that most amino acid changing SNPs are at very low frequencies
suggesting strong deleterious effects of most of them. An exception
is human PARP4 which shows an excess of high-frequency non-
synonymous polymorphisms. Based on a sliding window approach
we observed a signal of population differentiation associated with
a population speciﬁc negative value of Fay and Wu’s H in PARP4,
which may  be interpreted as a signature of positive selection. Pre-
vious large scale analysis of human variation have not identiﬁed
PARP4 as a target of selection [79] (http://haplotter.uchicago.edu/).
One of the reasons may  be that earlier approaches have been limited
to the Hapmap2 dataset which was  restricted to three human
populations, while we  use an extended dataset with 14 different
populations. Interestingly there is evidence that PARP4 under-
goes nonhomologous recombination with a nearby pseudogene
(Dumont et al., personal communication) derived from common
variation of PARP4 and the pseudogene. This pattern can, however,
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also be found in the chimpanzee genome and therefore may  reﬂect
a distant evolutionary event rather than ongoing nonhomologous
recombination events. The signature of population differentia-
tion coincides with the end of the nonhomologous recombination
region, however it is difﬁcult to address the biological signiﬁcance.
The PARP4 homologous region that shows shared variation of the
PARP4 pseudogene covers the last 10 exons (≈700 aa), which is
not assigned to any domain function according to the InterPro
database [80] but the major vault protein (MVP) interacting region
[64,81].
5. Conclusion
Collectively, our results conﬁrmed our general hypothesis that
NAD biosynthetic enzymes are evolutionary more conserved while
NAD degrading enzymes show less conservation and potentially
are still undergoing functional diversiﬁcation. However, we  also
showed that evolutionary patterns may  differ between species
and that there is a substantial evolutionary heterogeneity even
within enzyme families (e.g. NMNATs, PARPs). We  also stress that
exceptional characteristics of particular enzymes may  have an
evolutionary impact, e.g. macro domains as targets for positive
selection, the role of nonhomologous recombination or evolution-
ary heterogeneity within enzymes caused by ISTIDs. Taken together
our ﬁndings provide a valuable example of how molecular evo-
lution and population genetics can shed additional light on the
functional characterization of enzymes and the networks they are
involved in.
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